enGene Therapeutics (ENGN) Cash from Financing Activities (2023 - 2026)
enGene Therapeutics (ENGN) reported Cash from Financing Activities of $23,000 for fiscal Q3 2026 (quarter ended Jul 31, 2026), compared with -$667,000 a year earlier and down 68.9% from the prior quarter.
enGene Therapeutics (ENGN) Cash from Financing Activities (2023 - 2026) Analysis & Trends
Over the twelve months ended Jul 31, 2026, enGene Therapeutics' Cash from Financing Activities came in at $143.75 million, up 140.8% year-over-year; for FY2025 (ended Oct 31, 2025), it came in at $1.52 million, down 99.4% from FY2024.
- Cash from Financing Activities has a three-year compound annual growth rate of -62.1% (FY2022 to FY2025).
- By fiscal year, Cash from Financing Activities came in at $265.72 million in FY2024 (+208.4%), $86.15 million in FY2023 (+208.0%) and $27.97 million in FY2022.
- Five-year quarterly Cash from Financing Activities spans a low of -$667,000 in fiscal Q3 2025 and a high of $193.51 million in fiscal Q2 2024.
- Year over year, Cash from Financing Activities gained in 1 of the last five quarters, with an average decline of 68.2%.
- Per Business Quant data, the three fiscal quarters before Q3 2026 came in at $74,000 (Q2 2026), $141.66 million (Q1 2026) and $1.99 million (Q4 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | -8.78 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | -5.05 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 1.76 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | -2.02 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | -47.00 Mn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | -1.48 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 2.34 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | -3.66 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | -426.70 Mn |
| 10 | enGene Therapeutics | 134.03 Mn | 134.03 Mn | - | 23,000.00 |
Historic Data
| Date | Value |
|---|---|
| Jul 31, 2026 | 23,000.00 |
| Apr 30, 2026 | 74,000.00 |
| Jan 31, 2026 | 141.66 Mn |
| Oct 31, 2025 | 1.99 Mn |
| Jul 31, 2025 | -667,000.00 |
| Apr 30, 2025 | 199,000.00 |
| Jan 31, 2025 | 1,000.00 |
| Oct 31, 2024 | 60.16 Mn |
| Jul 31, 2024 | 51,000.00 |
| Apr 30, 2024 | 193.51 Mn |
| Jan 31, 2024 | 12.00 Mn |
| Oct 31, 2023 | 50.84 Mn |
| Jul 31, 2023 | 27.55 Mn |
| Apr 30, 2023 | 7.76 Mn |
| Jan 31, 2023 | -10,000.00 |
enGene Therapeutics Cash from Financing Activities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-from-financing-activities&ticker=ENGN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-from-financing-activities", "ticker": "ENGN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-from-financing-activities&ticker=ENGN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();